Abstract

Hypertensive disorders affect as many as 10% of pregnancies worldwide. Largely because of safety concerns, hydralazine use has declined whereas

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call